Lars Jørgen Østergaard

Differences in antiretroviral regimens do not impact safety or level of latency reversal in persons receiving romidepsin

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Original languageEnglish
JournalAIDS
Volume32
Issue12
Pages (from-to)1729-1731
Number of pages3
ISSN0269-9370
DOIs
Publication statusPublished - 31 Jul 2018

See relations at Aarhus University Citationformats

ID: 130584182